RCM
ABBV icon

Rotella Capital Management’s AbbVie ABBV Stock Holding History

Rotella Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-7,604
Closed -$450K – 9
2015
Q4 		$450K Buy
+7,604
New +$438K 0.4% 56

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Rotella Capital Management's ABBV Position: Q1 2016 in Review

Rotella Capital Management sold out of AbbVie (ABBV) in Q1 2016, closing a stake of 7,604 shares — an estimated $450K sold.

Rotella Capital Management first reported a position in ABBV in Q4 2015 and held it in 1 quarter. The position peaked at $450K in Q4 2015. 1,639 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

  • Rotella Capital Management reported no remaining AbbVie position as of Q1 2016 after selling out during the quarter.
  • Rotella Capital Management sold 7,604 AbbVie shares in Q1 2016, an estimated $450K.
  • Rotella Capital Management first reported a position in AbbVie in Q4 2015 and held it in 1 quarter.
  • Rotella Capital Management's AbbVie position peaked at $450K in Q4 2015.
  • 1,639 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on Rotella Capital Management's 13F filing for Q1 2016, filed 13 May 2016.